Hepatobiliary Tumor Organoids Reveal HLA Class I Neoantigen Landscape and Antitumoral Activity of Neoantigen Peptide Enhanced with Immune Checkpoint Inhibitors

Author:

Wang Wenwen1,Yuan Tinggan234,Ma Lili234,Zhu Yanjing56,Bao Jinxia7,Zhao Xiaofang1,Zhao Yan8,Zong Yali8,Zhang Yani8,Yang Shuai1,Qiu Xinyao1,Shen Siyun56,Wu Rui9,Wu Tong56,Wang Hongyang156,Gao Dong41011,Wang Peng234,Chen Lei161213ORCID

Affiliation:

1. Fudan University Shanghai Cancer Center Department of Oncology Shanghai Medical College Fudan University Shanghai 200032 China

2. School of Life Science and Technology ShanghaiTech University Shanghai 201210 China

3. CAS Key Laboratory of Computational Biology Shanghai Institute of Nutrition and Health Shanghai Institutes for Biological Sciences Chinese Academy of Sciences Shanghai 200031 China

4. University of Chinese Academy of Sciences Beijing 100049 China

5. The International Cooperation Laboratory on Signal Transduction Eastern Hepatobiliary Surgery Hospital Second Military Medical University Shanghai 200438 China

6. National Center for Liver Cancer Shanghai 200441 China

7. School of Medicine Nanjing University Nanjing 210093 China

8. Institute of Metabolism and Integrative Biology Fudan University Shanghai 200433 China

9. Department of Biliary Surgery I Eastern Hepatobiliary Surgery Hospital Second Military Medical University Shanghai 200438 China

10. State Key Laboratory of Cell Biology Shanghai Key Laboratory of Molecular Andrology Shanghai Institute of Biochemistry and Cell Biology CAS Center for Excellence in Molecular Cell Science Chinese Academy of Sciences Shanghai 200031 China

11. Institute for Stem Cell and Regeneration Chinese Academy of Sciences Beijing 100101 China

12. Key Laboratory of Signaling Regulation and Targeting Therapy of Liver Cancer (SMMU) Ministry of Education Shanghai 200438 China

13. Shanghai Key Laboratory of Hepatobiliary Tumor Biology (EHBH) Shanghai 200438 China

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3